Medical Second Opinion
Moderator: The global medical second opinion market is projected to grow from $7.4 billion in 2025 to $18.2 billion by 2032 . What is driving this growth?
A (Clinician): Patient empowerment and the rise of precision medicine. For oncology or rare diseases, a second opinion can literally change the treatment pathway. No single physician knows everything.
B (Health Economist): It's also about cost containment. Insurers are realizing that paying $500 for a second opinion to avoid a $50,000 unnecessary surgery or misdiagnosis is a massive ROI.
C (Tech Entrepreneur): Telehealth is the enabler. You no longer need to fly to Mayo Clinic or MD Anderson. Digital platforms now integrate AI for record sorting and connect patients to global specialists remotely.
D (Patient Advocate): But access is unequal. This market growth targets the "worried well" or high-net-worth individuals. Low-income patients with Medicaid rarely get a second opinion covered. We need to democratize this.